DocGo Inc. provided earnings for the year 2022. The company sees strong demand from customers for both mobile health and transportation services and anticipates 2022 revenue to be approximately $400 million to $420 million, representing growth of 27%-32% over 2021, or a 65% increase if exclude non-recurring Covid testing revenue from the second half of both years.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.075 USD | -3.91% | +2.52% | -44.62% |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.62% | 325M | |
-0.60% | 3.1B | |
0.00% | 1.95B | |
+19.30% | 1.78B | |
-19.32% | 419M | |
-21.46% | 171M | |
-15.15% | 134M | |
+1.92% | 67.93M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings for the Year 2022